Models for measuring metabolic chemical changes in the metastasis of high grade serous ovarian cancer: fallopian tube, ovary, and omentum.
Journal
Molecular omics
ISSN: 2515-4184
Titre abrégé: Mol Omics
Pays: England
ID NLM: 101713384
Informations de publication
Date de publication:
06 12 2021
06 12 2021
Historique:
pubmed:
3
8
2021
medline:
29
1
2022
entrez:
2
8
2021
Statut:
epublish
Résumé
Ovarian cancer (OC) is the most lethal gynecologic malignancy and high grade serous ovarian cancer (HGSOC) is the most common and deadly subtype, accounting for 70-80% of OC deaths. HGSOC has a distinct pattern of metastasis as many believe it originates in the fallopian tube and then it metastasizes first to the ovary, and later to the adipose-rich omentum. Metabolomics has been heavily utilized to investigate metabolite changes in HGSOC tumors and metastasis. Generally, metabolomics studies have traditionally been applied to biospecimens from patients or animal models; a number of recent studies have combined metabolomics with innovative cell-culture techniques to model the HGSOC metastatic microenvironment for the investigation of cell-to-cell communication. The purpose of this review is to serve as a tool for researchers aiming to model the metastasis of HGSOC for metabolomics analyses. It will provide a comprehensive overview of current knowledge on the origin and pattern of metastasis of HGSOC and discuss the advantages and limitations of different model systems to help investigators choose the best model for their research goals, with a special emphasis on compatibility with different metabolomics modalities. It will also examine what is presently known about the role of small molecules in the origin and metastasis of HGSOC.
Identifiants
pubmed: 34338690
doi: 10.1039/d1mo00074h
pmc: PMC8649074
mid: NIHMS1730680
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
819-832Subventions
Organisme : NCI NIH HHS
ID : R01 CA240423
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM125943
Pays : United States
Références
Am J Pathol. 2004 May;164(5):1511-8
pubmed: 15111296
Endocr Dev. 2010;19:45-52
pubmed: 20551667
Hum Reprod. 1990 Jan;5(1):25-31
pubmed: 2182659
J Proteome Res. 2013 Jan 4;12(1):505-12
pubmed: 23163809
Transl Res. 2016 Sep;175:92-102.e2
pubmed: 27083386
Cancer Res. 2016 Jan 1;76(1):10-7
pubmed: 26669862
NMR Biomed. 2000 Aug;13(5):297-305
pubmed: 10960920
Virchows Arch. 2005 Sep;447(3):626-33
pubmed: 15968547
Lancet. 2007 May 19;369(9574):1703-10
pubmed: 17512855
Eur J Gynaecol Oncol. 2008;29(5):511-4
pubmed: 19051824
Int J Cancer. 1996 Sep 17;67(6):816-20
pubmed: 8824553
Int J Cancer. 2015 Feb 1;136(3):516-26
pubmed: 24895217
Metabolomics. 2016 Apr;12(4):
pubmed: 28819352
Nat Commun. 2015 Dec 08;6:8989
pubmed: 26643275
Analyst. 2018 Feb 7;143(3):654-661
pubmed: 29323367
F1000Res. 2017 Jul 19;6:1148
pubmed: 28781759
J Nutr Biochem. 1999 Feb;10(2):66-88
pubmed: 15539274
Anal Bioanal Chem. 2018 Feb;410(5):1583-1594
pubmed: 29282499
Int J Cancer. 2007 Oct 1;121(7):1463-72
pubmed: 17546601
Mol Cancer Res. 2019 Aug;17(8):1710-1720
pubmed: 31110157
J Natl Cancer Inst. 1983 Oct;71(4):717-21
pubmed: 6578367
Am J Surg Pathol. 2007 Feb;31(2):161-9
pubmed: 17255760
Lancet. 1971 Jul 17;2(7716):163
pubmed: 4104488
Nat Commun. 2017 Oct 17;8(1):990
pubmed: 29042553
Cancer Res. 1994 Mar 1;54(5):1352-4
pubmed: 7509718
J Proteome Res. 2019 Aug 2;18(8):3184-3194
pubmed: 31290664
J Lipid Res. 2011 Jun;52(6):1247-1255
pubmed: 21421848
Trends Cancer. 2017 Nov;3(11):748-752
pubmed: 29120750
Gynecol Oncol. 2012 Nov;127(2):379-83
pubmed: 22835718
Nat Med. 2011 Oct 30;17(11):1498-503
pubmed: 22037646
Hum Reprod. 2013 Jan;28(1):224-9
pubmed: 23019297
Mol Carcinog. 2007 Oct;46(10):872-85
pubmed: 17455221
Nat Rev Cancer. 2015 Nov;15(11):668-79
pubmed: 26493647
Cancers (Basel). 2018 Aug 09;10(8):
pubmed: 30096959
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Sci Rep. 2017 Jan 04;7:39999
pubmed: 28051182
Mol Cell Proteomics. 2004 Apr;3(4):355-66
pubmed: 14764655
Cancer Causes Control. 2013 Dec;24(12):2197-206
pubmed: 24077761
Cancer Cell. 2014 Jul 14;26(1):77-91
pubmed: 25026212
Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1185-91
pubmed: 15247129
CA Cancer J Clin. 2018 Jul;68(4):284-296
pubmed: 29809280
Biochem J. 1995 Aug 1;309 ( Pt 3):933-40
pubmed: 7639713
World J Hepatol. 2010 Sep 27;2(9):337-44
pubmed: 21161018
Cancer Res. 2006 Mar 15;66(6):3006-14
pubmed: 16540649
Clin Exp Metastasis. 2010 Mar;27(3):185-96
pubmed: 20229256
Expert Rev Mol Med. 2007 Oct 15;9(28):1-18
pubmed: 17935635
Int J Gynecol Cancer. 2009 May;19(4):531-9
pubmed: 19509547
BMC Cell Biol. 2013 Sep 27;14:43
pubmed: 24070420
Pleura Peritoneum. 2020 May 12;5(2):20200113
pubmed: 32566728
Sci Rep. 2015 Nov 17;5:16351
pubmed: 26573008
Cell Res. 2002 Dec;12(5-6):311-20
pubmed: 12528889
Cell Physiol Biochem. 2018;51(3):1134-1148
pubmed: 30476914
FEMS Microbiol Lett. 2019 Jun 1;366(11):
pubmed: 31210257
J Transl Med. 2004 Jun 25;2(1):23
pubmed: 15219235
J Vis Exp. 2019 Apr 3;(146):
pubmed: 31009015
Br J Cancer. 1980 Jan;41(1):52-61
pubmed: 7362779
Analyst. 2016 Jan 21;141(2):595-605
pubmed: 26402586
Proteomics. 2016 Jun;16(11-12):1814-21
pubmed: 27198560
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Biol Cell. 1994;82(2-3):103-7
pubmed: 7606207
Cancer Res. 2015 Jan 15;75(2):456-71
pubmed: 25425006
Cancer Res. 2009 Sep 1;69(17):7121-9
pubmed: 19706774
Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617
pubmed: 29140435
Endocr Relat Cancer. 2011 Sep 20;18(5):627-42
pubmed: 21813729
J Proteome Res. 2015 Feb 6;14(2):917-27
pubmed: 25567202
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3070-4
pubmed: 1348364
Mol Pharmacol. 2002 Sep;62(3):660-71
pubmed: 12181443
Cell Rep. 2017 Mar 14;18(11):2557-2565
pubmed: 28297660
Cancer Res. 2018 Jul 1;78(13):3560-3573
pubmed: 29739756
Lipids Health Dis. 2015 Jul 15;14:72
pubmed: 26174150
Semin Cell Dev Biol. 2004 Oct;15(5):503-12
pubmed: 15271295
Nat Rev Cancer. 2011 Sep 23;11(10):719-25
pubmed: 21941283
Metabolomics. 2017 Oct;13:
pubmed: 29430218
Sci Rep. 2014 Aug 19;4:6116
pubmed: 25135607
Clin Chim Acta. 2012 May 18;413(9-10):861-8
pubmed: 22309680
Cancers (Basel). 2021 Jan 26;13(3):
pubmed: 33530497
Mol Biosyst. 2015 Feb;11(2):516-21
pubmed: 25424060
Nat Prod Rep. 2020 Feb 26;37(2):150-162
pubmed: 31364647
ACS Cent Sci. 2018 Oct 24;4(10):1360-1370
pubmed: 30410974
Crit Rev Clin Lab Sci. 2006;43(2):143-81
pubmed: 16517421
Exp Cell Biol. 1987;55(4):194-208
pubmed: 3678576
Anat Embryol (Berl). 2005 Feb;209(3):251-61
pubmed: 15662530
Curr Probl Surg. 1986 Nov;23(11):789-865
pubmed: 3780294
Am J Pathol. 2016 Apr;186(4):733-47
pubmed: 27012190
Int J Cancer. 2005 Feb 20;113(5):782-8
pubmed: 15499633
Biochem Pharmacol. 2014 Nov 1;92(1):43-54
pubmed: 25168677
Int J Gynecol Pathol. 2008 Jan;27(1):1-9
pubmed: 18156967
Carcinogenesis. 2019 Mar 12;40(1):41-51
pubmed: 30475985
Pathol Res Pract. 2000;196(7):469-75
pubmed: 10926324
J Transl Med. 2015 Jul 14;13:223
pubmed: 26169745
Reprod Domest Anim. 2019 Sep;54 Suppl 3:38-45
pubmed: 31512315
JAMA. 2001 Mar 21;285(11):1460-5
pubmed: 11255422
Ann N Y Acad Sci. 2000 Apr;905:188-208
pubmed: 10818454
Cancer Cell. 2013 Dec 9;24(6):751-65
pubmed: 24332043
Oncogene. 2010 Feb 25;29(8):1103-13
pubmed: 19935705
PLoS One. 2011;6(5):e19963
pubmed: 21625518
Nat Rev Cancer. 2017 Jan;17(1):65-74
pubmed: 27885265
Gynecol Oncol. 2011 Feb;120(2):189-92
pubmed: 21112078
Acta Obstet Gynecol Scand. 2015 Jan;94(1):86-94
pubmed: 25256594
J Nutr Health Aging. 2002;6(1):39-42
pubmed: 11813080
Cell. 2016 May 19;165(5):1092-1105
pubmed: 27133165
Neoplasia. 1999 Aug;1(3):226-30
pubmed: 10935477
Clin Cancer Res. 2005 Sep 1;11(17):6116-26
pubmed: 16144910
Reprod Biol Endocrinol. 2003 Oct 07;1:73
pubmed: 14577831
Ginekol Pol. 2018;89(10):568-572
pubmed: 30393846
Nat Commun. 2017 Mar 28;8:14584
pubmed: 28350383
Exp Cell Res. 1985 Oct;160(2):499-513
pubmed: 3899694
Cancer Res. 2020 Apr 15;80(8):1748-1761
pubmed: 32054768
J Biol Chem. 2007 Feb 16;282(7):4924-4931
pubmed: 17158885
J Pathol. 2007 Jan;211(1):26-35
pubmed: 17117391
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
Am J Pathol. 2010 Sep;177(3):1053-64
pubmed: 20651229
Carcinogenesis. 2012 Jan;33(1):20-9
pubmed: 22021907
J Nutr. 2000 Feb;130(2):129-32
pubmed: 10720158
J Oncol. 2011;2011:174019
pubmed: 21577256
Oncogenesis. 2020 May 29;9(5):55
pubmed: 32471985
Obes Rev. 2016 Nov;17(11):1015-1029
pubmed: 27432523
Int J Cancer. 1997 Apr 22;74(2):193-8
pubmed: 9133455
J Biol Chem. 2004 Mar 5;279(10):9653-61
pubmed: 14670967
Commun Biol. 2019 Jul 31;2:281
pubmed: 31372520
JAMA. 2002 Jul 17;288(3):334-41
pubmed: 12117398
J Vis Exp. 2017 Feb 18;(120):
pubmed: 28287578
J Natl Cancer Inst. 2015 Jan 27;107(2):
pubmed: 25628372
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):31993-32004
pubmed: 33262282
PLoS One. 2016 May 09;11(5):e0154837
pubmed: 27159635
Mol Cancer Ther. 2009 Jun;8(6):1692-701
pubmed: 19509252